RVX-408

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameRVX-408

Drug Alias NameNexVas PR backup compound (Resverlogix)RVX-408

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionApolipoprotein A-I stimulants

TargetsApolipoprotein A-I

Therapy Area/IndicationsCardiovascular Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesResverlogix Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesResverlogix Corp

Active IndicationsN/A

Inactive IndicationsCardiovascular Diseases

ATC CodeN/A